These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM. J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [Abstract] [Full Text] [Related]
5. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Moreira DM, Anderson T, Gerber L, Thomas JA, Bañez LL, McKeever MG, Hoyo C, Grant D, Jayachandran J, Freedland SJ. Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753 [Abstract] [Full Text] [Related]
6. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258 [Abstract] [Full Text] [Related]
10. Diabetes mellitus and the risk of prostate cancer in Italy. Tavani A, Gallus S, Bertuzzi M, Dal Maso L, Zucchetto A, Negri E, Franceschi S, Ramazzotti V, Montella M, La Vecchia C. Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192 [Abstract] [Full Text] [Related]
12. Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Freedland SJ, Terris MK, Platz EA, Presti JC. Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911 [Abstract] [Full Text] [Related]
13. Finasteride decreases the risk of prostatic intraepithelial neoplasia. Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA. J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284 [Abstract] [Full Text] [Related]
14. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA. J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486 [Abstract] [Full Text] [Related]
15. High-grade prostate cancer and finasteride. Lebdai S, Bigot P, Azzouzi AR. BJU Int; 2010 Feb 20; 105(4):456-9. PubMed ID: 19930174 [Abstract] [Full Text] [Related]
16. Height, body weight, and risk of prostate cancer. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Cancer Epidemiol Biomarkers Prev; 1997 Aug 20; 6(8):557-63. PubMed ID: 9264267 [Abstract] [Full Text] [Related]
17. A better prognosis for obese men with prostate cancer. Daniell HW. J Urol; 1996 Jan 20; 155(1):220-5. PubMed ID: 7490839 [Abstract] [Full Text] [Related]
18. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia. Fowke JH, Motley SS, Wills M, Cookson MS, Concepcion RS, Eckstein CW, Chang SS, Smith JA. Cancer Causes Control; 2007 May 20; 18(4):375-84. PubMed ID: 17334811 [Abstract] [Full Text] [Related]
19. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Hubbard JS, Rohrmann S, Landis PK, Metter EJ, Muller DC, Andres R, Carter HB, Platz EA. Urology; 2004 Feb 20; 63(2):253-8. PubMed ID: 14972466 [Abstract] [Full Text] [Related]
20. Obesity and the risk of prostate cancer (United States). Bradbury BD, Wilk JB, Kaye JA. Cancer Causes Control; 2005 Aug 20; 16(6):637-41. PubMed ID: 16049801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]